
### [NCIT:C7489](http://purl.obolibrary.org/obo/NCIT_C7489)
**Label:** Anal Canal Carcinoma

**Subclasses:** [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96551](http://purl.obolibrary.org/obo/NCIT_C96551) (Anal Canal Small Cell Neuroendocrine Carcinoma), [NCIT:C7469](http://purl.obolibrary.org/obo/NCIT_C7469) (Anal Canal Squamous Cell Carcinoma), [NCIT:C133787](http://purl.obolibrary.org/obo/NCIT_C133787) (Anal Canal Cancer by AJCC v6 and v7 Stage), [NCIT:C7776](http://purl.obolibrary.org/obo/NCIT_C7776) (Stage III Anal Canal Cancer AJCC v6 and v7), [NCIT:C96553](http://purl.obolibrary.org/obo/NCIT_C96553) (Anal Canal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C5612](http://purl.obolibrary.org/obo/NCIT_C5612) (Metastatic Anal Canal Carcinoma), [NCIT:C7794](http://purl.obolibrary.org/obo/NCIT_C7794) (Stage 0 Anal Canal Cancer AJCC v6 and v7), [NCIT:C9037](http://purl.obolibrary.org/obo/NCIT_C9037) (Stage I Anal Canal Cancer AJCC v6 and v7), [NCIT:C6873](http://purl.obolibrary.org/obo/NCIT_C6873) (Stage IV Anal Canal Cancer AJCC v6 and v7), [NCIT:C7775](http://purl.obolibrary.org/obo/NCIT_C7775) (Stage II Anal Canal Cancer AJCC v6 and v7), [NCIT:C7477](http://purl.obolibrary.org/obo/NCIT_C7477) (Paget Disease of the Anal Canal), [NCIT:C7471](http://purl.obolibrary.org/obo/NCIT_C7471) (Anal Canal Adenocarcinoma), [NCIT:C7793](http://purl.obolibrary.org/obo/NCIT_C7793) (Recurrent Anal Canal Carcinoma), [NCIT:C5606](http://purl.obolibrary.org/obo/NCIT_C5606) (Anal Mucinous Adenocarcinoma), [NCIT:C96549](http://purl.obolibrary.org/obo/NCIT_C96549) (Anal Canal Neuroendocrine Carcinoma), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36821](http://purl.obolibrary.org/obo/NCIT_C36821) (Malignant Neuroendocrine Large Cell) 62.50%
- Thing 52.03%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) 51.73%
- [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) 47.86%
- [NCIT:C36929](http://purl.obolibrary.org/obo/NCIT_C36929) (Malignant Endocrine Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36860](http://purl.obolibrary.org/obo/NCIT_C36860) (Malignant Small Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36795](http://purl.obolibrary.org/obo/NCIT_C36795) (Malignant Epithelial Small Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 47.86%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 47.86%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 47.86%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 47.86%


